The influence of low molecular weight heparin medication on plasma DNA in pregnant women.
Grömminger, Sebastian
The influence of low molecular weight heparin medication on plasma DNA in pregnant women. [electronic resource] - Prenatal diagnosis Nov 2015 - 1155-7 p. digital
Publication Type: Letter; Research Support, Non-U.S. Gov't
1097-0223
10.1002/pd.4668 doi
Anticoagulants--therapeutic use
Blood Specimen Collection--methods
Chromosome Disorders--diagnosis
Chromosomes, Human, Pair 13
Chromosomes, Human, Pair 18
Cytosine
DNA--blood
Diagnostic Errors--prevention & control
Down Syndrome--diagnosis
False Positive Reactions
Female
Guanosine
Heparin, Low-Molecular-Weight--therapeutic use
Humans
Plasma
Pregnancy
Prenatal Diagnosis
Time Factors
Trisomy--diagnosis
Trisomy 13 Syndrome
Trisomy 18 Syndrome
The influence of low molecular weight heparin medication on plasma DNA in pregnant women. [electronic resource] - Prenatal diagnosis Nov 2015 - 1155-7 p. digital
Publication Type: Letter; Research Support, Non-U.S. Gov't
1097-0223
10.1002/pd.4668 doi
Anticoagulants--therapeutic use
Blood Specimen Collection--methods
Chromosome Disorders--diagnosis
Chromosomes, Human, Pair 13
Chromosomes, Human, Pair 18
Cytosine
DNA--blood
Diagnostic Errors--prevention & control
Down Syndrome--diagnosis
False Positive Reactions
Female
Guanosine
Heparin, Low-Molecular-Weight--therapeutic use
Humans
Plasma
Pregnancy
Prenatal Diagnosis
Time Factors
Trisomy--diagnosis
Trisomy 13 Syndrome
Trisomy 18 Syndrome